---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-26-000012"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:39:44.701235+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad updates Sartorius AG 2025 financials: sales €3.54B, net profit €230M

## Summary
- Sartorius AG 2025: sales €3,538.1M, gross profit €1,636.7M, EBIT €542.6M, net profit €230.4M.
- Balance sheet: current assets €1,766.2M, non-current €7,951.1M, total equity €3,867.2M.
- Operating cash flow €837.0M; investing outflow €513.7M; financing outflow €591.4M.
- Update follows Sartorius’ Feb 16, 2026 release; Bio-Rad’s 10-K investment disclosure updated accordingly.

## SEC filing metadata
- accession: 0000012208-26-000012
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220826000012/0000012208-26-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220826000012/bio-20260219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-26-000012
- JSON: https://secwatch.observer/filing/0000012208-26-000012.json
- Plain text: https://secwatch.observer/filing/0000012208-26-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.